Company: INDP
Filing Date: 2025-03-27
Form Type: DRS
Source: 0001641172-25-000975
Chunk: 38

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-03-27
Form: DRS
Chunk 38
---
 expressing substantial doubt regarding the Company’s ability to continue as a going concern, and upon the authority of said firm as experts in accounting and auditing.

<div align='center'>incorporation of CERTAIN information by reference</div>

The SEC allows us to “incorporate by reference” the information we have filed with it, which means that we can disclose important information to you by referring you to those documents. The information we incorporate by reference is an important part of this prospectus, and later information that we file with the SEC will automatically update and supersede this information. We incorporate by reference the documents listed below and any future documents (excluding information furnished pursuant to Items 2.02 and 7.01 of Form 8-K) we file with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent to the date of this prospectus and prior to the termination of the offering:

| ● 
 ● | the                                                                                                                                
 Company’s Annual Report on Form                                                                                                    
 10-K for the fiscal year ended December 31, 2024, filed with the SEC on March 13, 2025;                                            
 our                                                                                                                                
 Current Reports on Form 8-K filed with the SEC on January                                                                          
 14, 2025, January                                                                                                                  
 31, 2025, and February                                                                                                             
 12, 2025; and                                                                                                                      |
|:--|:-----------------------------------------------------------------------------------------------------------------------------------|
| ● | the                                                                                                                                
 description of our shares of common stock contained in Item 1 of the Registration Statement on Form                                
 8-A (File No. 001-40652), filed with the SEC on July 23, 2021, including any amendment or report filed for the purpose of updating 
 such description.                                                                                                                  |

We are not, however, incorporating, in each case, any documents or information that we are deemed to furnish and not file in accordance with SEC rules.

Any statement contained in any document incorporated by reference herein will be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained in this prospectus or any prospectus supplement modifies or supersedes such statement. Any statement so modified or superseded will not be deemed, except as so modified or superseded, to constitute a part of this prospectus.

All reports and other documents we subsequently file pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act prior to the